AR and prostate carcinoma: Bioinformatic analysis of patient‐derived xenografts (PDXs), cell lines, and organoids identified three intrinsic transcriptional subtypes of mCRPC, including AR‐pathway prostate cancer (ARPC), MSPC, and neuroendocrine prostate cancer (NEPC) cells.